Advertisement

Neuromuscular Disease

  • David Pleasure
  • Shawn Bird
  • Steven Scherer
  • John Sladky
  • Donald Schotland

Abstract

This chapter illustrates diseases that involve the peripheral nervous system and skeletal muscle. In such diseases, the history and physical examination frequently provide sufficient data to arrive at the correct diagnosis. For example, autonomic dysfunction, distal limb weakness, hyporeflexia, and sensory loss in an adult with long-standing diabetes mellitus are probably due to diabetic neuropathy, and fluctuating weakness of bulbar and ocular muscles without sensory or reflex alterations strongly suggests myasthenia gravis. The clinical diagnosis can often be validated by specific immunochemical, biochemical, or molecular blood tests (Fig. 11-1).

Keywords

Duchenne Dystrophy Myotonic Dystrophy Compound Muscle Action Potential Chronic Inflammatory Demyelinating Polyneuropathy Onion Bulb 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Hermann DN, Griffin JW, Hauer P, et al.: Epidermal nerve fiber density and sural nerve morphometry in peripheral neuropathies. Neurology 1999, 53:1634–1640.CrossRefGoogle Scholar
  2. 2.
    Asbury AK, Gilliatt RW: The Clinical Approach to Neuropathy. In Peripheral Nerve Disorders. Edited by Asbury AK, Gilliatt RW. London: Butterworths; 1994: 1–20.Google Scholar
  3. 3.
    Lennon VA, Kryzer TJ, Griesmann GE, et al.: Calcium channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes. N Engl J Med 1995, 332:1467–1474.Google Scholar
  4. 4.
    Chaudhry V, Crawford TO: Stimulation single-fiber EMG in infant botulism. Muscle Nerve 1999, 22: 1698–1703.PubMedCrossRefGoogle Scholar
  5. 5.
    Pasternak C, Wong S, Elson EL: Mechanical function of dystrophin in muscle cells. J Cell Biol 1995, 128: 355–361.PubMedCrossRefGoogle Scholar
  6. 6.
    Chan YM, Bonnemann CG, Lidov HGM, Kunkel LM: Molecular organization of sarcoglycan complex in mouse myotubes in culture. J Cell Biol 1998, 143: 2033–2044.PubMedCrossRefGoogle Scholar
  7. 7.
    Mahadevan M, Tsilfidis C, Sabourin L, et al.: Myotonic dystrophy mutation: an unstable CTG repeat in the 3’ untranslated region of the gene. Science 1992, 255:1253–1255.Google Scholar
  8. 8.
    Lieberman AP, Fischbeck KH: Triplet repeat expansion in neuromuscular disease. Muscle Nerve 2000, 23: 843–850.PubMedCrossRefGoogle Scholar
  9. 9.
    DiMauro S, Bonilla E, Davidson M, et al.: Mitochondria in neuromuscular disorders. Biochim Biophys Acta 1998, 1366:199–210.Google Scholar
  10. 10.
    Laing NG, Wilton SD, Akkari PA, et al.: A mutation in the alpha tropomyosin gene TPM3 associated with autosomal dominant nemaline myopathy. Nature Genet 1995, 9:75–79.Google Scholar
  11. 11.
    Johnston JJ, Kelley RI, Crawford TO, et al.: A novel nemaline myopathy in the Amish caused by a mutation in troponin TL. Am J Hum Genet 2000, 67:814–821.Google Scholar
  12. 12.
    McCarthy TV, Quane KA, Lynch PJ: Ryanodine receptor mutations in malignant hyperthermia and central core disease. Hum Mutat 2000, 15: 410–417.PubMedCrossRefGoogle Scholar
  13. 13.
    Sigurgeirsson B, Lindelof B, Edhag O, Allander E: Risk of cancer in patients with dermatomyositis or polymyositis: a population-based study. N Engl J Med 1992, 326: 363–367.PubMedCrossRefGoogle Scholar
  14. 14.
    Askanas V, Engel WK: Sporadic inclusion-body myositis and hereditary inclusion-body myopathies: current concepts of diagnosis and pathogenesis. Curr Opin Rheumatol 1998, 10: 530–542.PubMedCrossRefGoogle Scholar
  15. 15.
    Adams D, Samuel D, Goulon-Goeau C, et al.: The course and prognostic factors of familial amyloid polyneuropathy after liver transplantation. Brain 2000, 123:1495–1504.Google Scholar
  16. 16.
    Keller MP, Chance PF: Inherited neuropathies: from gene to disease. Brain Pathol 1999, 9: 327–341.PubMedCrossRefGoogle Scholar
  17. 17.
    La Spada AR, Roling DB, Harding AE, et al.: Meiotic stability and genotype-phenotype correlation of the ‘trinucleotide repeat in X-linked spinal and bulbar muscular atrophy. Nature Genet 1992, 2:301–304.Google Scholar
  18. 18.
    Pellizzoni L, Charroux B, Dreyfuss G: SMN mutants of spinal muscular atrophy patients are defective in binding to snRNP proteins. Proc Natl Acad Sci USA 1999, 96: 11167–111672.Google Scholar
  19. 19.
    Gurney ME, Liu R, Althaus JS, et al.: Mutant CuZn superoxide dismutase in motor neuron disease. J Inherit Metab Dis 1998; 21:587–597.Google Scholar
  20. 20.
    Peters A, Palay SL, Webster H deF: The Fine Structure of the Nervous System. New York: Oxford University Press; 1994.Google Scholar
  21. 21.
    Khella SL, Frost S, Hermann GA, et al.: Hepatitis C infection, cryoglobulinemia, and vasculitic neuropathy. Treatment with interferon alpha: case report and literature review. Neurology 1995, 45:407–411.Google Scholar
  22. 22.
    Rajkumar SV, Gertz MA, Kyle RA: Prognosis of patients with primary systemic amyloidosis who present with dominant neuropathy. Am J Med 1998, 104: 232–237.PubMedCrossRefGoogle Scholar
  23. 23.
    Arroyo EJ, Scherer SS: On the molecular architecture of myelinated fibers. Histochem Cell Biol 2000, 113: 1–18.PubMedCrossRefGoogle Scholar
  24. 24.
    Nobile-Orazio E, Meucci N, Baldini L, et al.: Long-term prognosis of neuropathy associated with anti-MAG IgM M-proteins and its relationship to immune therapies. Brain 2000, 123:710–717.Google Scholar

Copyright information

© Springer Science+Business Media New York 2003

Authors and Affiliations

  • David Pleasure
  • Shawn Bird
  • Steven Scherer
  • John Sladky
  • Donald Schotland

There are no affiliations available

Personalised recommendations